Following the U.S. Food and Drug Administration’s recent approval of Parsabiv™ (etelcalcetide), an IV formulation equivalent to the oral calcimimetic Sensipar® (cinacalcet), dialysis providers like … [Read more...]
Interoperability and a Framework for the Trusted Exchange HIT
We’ve talked the talk about Health Information Technology (HIT) interoperability for a long time, but progress has been slow. The 21st Century Cures Act legislates that diligent work on … [Read more...]
Intravenous Form of Sensipar® Has Been Approved by the FDA
Parsabiv™ (etelcalcetide), an IV formulation similar to the oral calcimimetic Sensipar® (cinicalset), was recently approved by the U.S. Food and Drug Administration to treat secondary … [Read more...]
